Exactly and Anavex haven't even designed and run any proper Confirmatory Randomised Precision Medicine Clinical Trials yet that irrevocably proves A2-73 works in some indication at least for some subgroups of patients - close but no cigar yet!
Anavex didn't design any drugs. It bought all of them.
With luck we will get a Conditional Marketing Authorisation, so that the company can finally get on with the task of doing what they should have done over two years ago, when they said they would - this time they can't escape because it will be a condition imposed on the company.